Data / Drug companies / Fexofenadine hydrochloride and pseudoephedrine hydrochloride
Fexofenadine hydrochloride and pseudoephedrine hydrochloride: 16 companies and 24 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Fexofenadine hydrochloride and pseudoephedrine hydrochloride is listed in the FDA National Drug Code Directory by 16 companies, with 24 products in commercial distribution. 21 of the products (87.5%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated, extended release; tablet, extended release, and the newest product started marketing on August 27, 2026.
The request: Get every company that lists fexofenadine hydrochloride and pseudoephedrine hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 16
- Products
- 24
- Generic (ANDA) products
- 21 (87.5%)
- Application numbers
- 6
- Routes
- Oral
- Brand names
- Allegra-D Allergy and Congestion, 12HR Allergy & Congestion Relief, Allegra-D
- openFDA record search
- api.fda.gov
Companies that list fexofenadine hydrochloride and pseudoephedrine hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Walgreen Company | 4 | tablet, film coated, extended release; tablet, extended release | Generic drugs (ANDA) | August 27, 2026 |
| Aurohealth LLC | 2 | tablet, film coated, extended release | Generic drugs (ANDA) | April 17, 2025 |
| CVS Pharmacy | 2 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | August 27, 2020 |
| CVS Woonsocket Prescription Center, Incorporated | 2 | tablet, extended release; tablet, film coated, extended release | Generic drugs (ANDA) | November 17, 2022 |
| Chattem, Inc. | 2 | tablet, film coated, extended release | New drug applications (NDA) | March 3, 2011 |
| Kroger Company | 2 | tablet, film coated, extended release; tablet, extended release | Generic drugs (ANDA) | March 31, 2022 |
| A-S Medication Solutions | 1 | tablet, film coated, extended release | New drug applications (NDA) | March 3, 2011 |
| Amerisource Bergen | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | March 1, 2018 |
| Cardinal Health 110, LLC. DBA Leader | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | May 15, 2024 |
| H E B | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | August 1, 2018 |
| Ohm Laboratories Inc. | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | March 1, 2018 |
| Publix Super Markets, Inc | 1 | tablet, extended release | Generic drugs (ANDA) | November 8, 2021 |
| Rite Aid Corporation | 1 | tablet, extended release | Generic drugs (ANDA) | March 31, 2022 |
| Strategic Sourcing Services LLC | 1 | tablet, extended release | Generic drugs (ANDA) | March 31, 2022 |
| Sun Pharmaceutical Industries, Inc. | 1 | tablet, film coated, extended release | Generic drugs (ANDA) | March 1, 2018 |
| Walmart Inc. | 1 | tablet, extended release | Generic drugs (ANDA) | March 31, 2022 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated, extended release | 16 | 66.7% |
| Tablet, extended release | 8 | 33.3% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 21 | 87.5% |
| New drug applications (NDA) | 3 | 12.5% |
Pharmacologic classes
| Class | Products |
|---|---|
| Histamine-1 Receptor Antagonist | 24 |
| alpha-Adrenergic Agonist | 24 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.